The FDA has recently issued a warning that links Tardive Dyskinesia to Reglan use in infants
Tardive Dyskinesia in Children: an Overview
Reglan, also known as Metoclopramide, is a prescription drug used to treat infant reflux disorder. Recently, the FDA issued a warning that links Tardive Dyskinesia to Reglan use in infants. Tardive Dyskinesia is a serious side effect that is primarily characterized by involuntary and repetitive body movements. It can cause random facial and body movements, as well as uncontrollable swaying movements. Manufacturers of medications such as Reglan have been aware of the possible side effects for many years, yet still continue to manufacture and market the drug.
Many infants suffer from gastrosophageal reflux, also known as GERD. GERD can be painful for babies and prevent them from getting the necessary nutrition to grow. Accordingly, many doctors choose to treat GERD with medication. Some doctors prescribe Reglan to treat GERD, although this drug has not been approved by the FDA for use in infants or children.
GERD is commonly overlooked in children under 1 year of age due to their feedings, which often produce spit-up or repeated regurgitation. Identifying GERD is not easy, as its signs are commonly seen in babies and small children, such as:
- Mild Heartburn
- Prolonged Coughing
- Other respiratory problems such as asthma or wheezing